Synthetic Blood and Virginia University sign licensing agreement
The Virginia Commonwealth University (VCU) discoveries relate to non-pulmonary oxygenation, enhanced oxygen transport to tissue, and gas-based wound and tissue therapeutics. Chris Stern, chairman and CEO of Synthetic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.